Fukuoka, Japan

Hidekazu Aratani

This inventor holds 1 USPTO granted patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidekazu Aratani. Retrieved from https://idiyas.com/inventor/hidekazu-aratani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Hidekazu Aratani

Introduction

Hidekazu Aratani is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of immunosuppressive drugs. His work has the potential to impact the treatment of various medical conditions.

Latest Patents

Aratani holds a patent for an immunosuppressive drug, showcasing his innovative approach to addressing medical challenges. This patent represents his commitment to advancing healthcare solutions.

Career Highlights

Aratani is currently employed at Yoshitomi Pharmaceutical Industries, Ltd., where he continues to contribute to pharmaceutical research and development. His role at the company allows him to collaborate with other experts in the field.

Collaborations

Some of his notable coworkers include Takeki Okumoto and Kenji Chiba. Their collaboration fosters a creative environment that enhances the development of new pharmaceutical innovations.

Conclusion

Hidekazu Aratani's work in immunosuppressive drugs exemplifies the impact of dedicated inventors in the pharmaceutical industry. His contributions are vital for advancing medical treatments and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…